au.\*:("ROVATI, B")
Results 1 to 6 of 6
Selection :
AL amyloidosis : characterization of amyloidogenic cells by anti-idiotypic monoclonal antibodiesPERFETTI, V; BELLOTTI, V; GARINI, P et al.Laboratory investigation. 1994, Vol 71, Num 6, pp 853-861, issn 0023-6837Article
Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patientsRONZONI, M; MANZONI, M; DANOVA, M et al.Annals of oncology. 2010, Vol 21, Num 12, pp 2382-2389, issn 0923-7534, 8 p.Article
prophylactic use of rabbit ATG vs horse ALG in heart-transplanted patients under sandimmun (CyA) therapy: clinical and immunological effectsIPPOLITI, G; ROVATI, B; VIGANO, M et al.Clinical transplantation. 1989, Vol 3, Num 4, pp 204-208, issn 0902-0063Article
Immunological Effects of Bevacizumab-Based Treatment in Metastatic Colorectal CancerMANZONI, M; ROVATI, B; DANOVA, M et al.Oncology. 2010, Vol 79, Num 3-4, pp 187-196, issn 0030-2414, 10 p.Article
Reduced number and function of peripheral dendritic cells in coeliac diseaseCICCOCIOPPO, R; RICCI, G; ROVATI, B et al.Clinical and experimental immunology (Print). 2007, Vol 149, Num 3, pp 487-496, issn 0009-9104, 10 p.Article
Cyclosporine in treatment of progressive systemic sclerosis : clinical and immunologic findingsIPPOLITI, G; MIORI, L; NEGRI, M et al.Transplantation proceedings. 1994, Vol 26, Num 6, pp 3117-3118, issn 0041-1345Conference Paper